B. Metzler Seel. Sohn & Co. Ag Ideaya Biosciences, Inc. Transaction History
B. Metzler Seel. Sohn & Co. Ag
- $9.53 Billion
- Q4 2024
A detailed history of B. Metzler Seel. Sohn & Co. Ag transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, B. Metzler Seel. Sohn & Co. Ag holds 27,276 shares of IDYA stock, worth $503,787. This represents 0.01% of its overall portfolio holdings.
Number of Shares
27,276Holding current value
$503,787% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding IDYA
# of Institutions
213Shares Held
79.9MCall Options Held
39.6KPut Options Held
24.1K-
Black Rock Inc. New York, NY6.81MShares$126 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X05.86MShares$108 Million0.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.08MShares$93.8 Million0.0% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA5.06MShares$93.5 Million0.3% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.87MShares$71.4 Million0.01% of portfolio
About IDEAYA Biosciences, Inc.
- Ticker IDYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,067,700
- Market Cap $888M
- Description
- IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...